Table 2.

Histology classification of the tumors at baseline (safety population)

	n = 22
Adipocytic tumor—myxoid/round cell liposarcoma	2 (9.1%)
Adipocytic tumor—pleomorphic liposarcoma	1 (4.5%)
Carcinosarcoma	1 (4.5%)
Dedifferentiated liposarcoma	3 (13.6%)
Fibrohistiocytic tumor—undifferentiated pleomorphic sarcoma/malignant fibrous	4 (18.2%)
Smooth muscle tumors (leiomyosarcoma)	5 (22.7%)
Tumor of peripheral nerves—malignant peripheral nerve sheath tumor	1 (4.5%)
Tumor of uncertain differentiation—synovial sarcoma	2 (9.1%)
Tumor of uncertain differentiation—undifferentiated sarcoma/sarcoma NOS	2 (9.1%)
Undifferentiated endometrial sarcoma	1 (4.5%)